| |
Preclinical Antiviral Profiling of AB-161, an
Oral HBV Inhibitor
that Destabilizes HBV RNA and Suppresses HBsAg
(Global Hepatitis Summit 2023 Paris April 28)
|
| |
| |
Global Hepatitis Summit April 28 2023 Paris
Angela M Lam, Muhammad Sheraz, Fei Liu, Andrea Cuconati, Holly M Micolochick Steuer, Rose
Kowalski, Emily P Thi, Ingrid Graves, Dimitar Gotchev, Shuai Chen, Fran Xu, Amanda Pohl, Steven
Ring, Andrew G Cole, Troy O Harasym, Min Gao, Michael J Sofia
|
|
| |
| |
|
|
|
